|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 439.33 USD | +1.88% |
|
+5.81% | +34.22% |
| 08-21 | FTC Challenges Amgen's Patent Play in Enbrel Antitrust Case | DJ |
| 08-20 | Piper Sandler Adjusts Price Target on Amgen to $457 From $427, Maintains Overweight Rating | MT |
MarketScreener Strategies
Search
No results match your criteria
- Stock Market
- Stocks
- AMGN Stock
- News Amgen Inc.
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
